Loading...

Advances and application of radioimmunotherapy in non-Hodgkin lymphoma

The activity of radio-immuno conjugate in Non-Hodgkin Lymphoma (NHL) has resulted in FDA approval of two antibodies, Y(90) Ibritumomab tiuxetan and I(131) tositumomab. Both these agents target CD20, a receptor widely expressed in B-Cell NHL. These immunoconjugates deliver their radioactive payload t...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Stevens, Patrick L, Oluwole, Olalekan, Reddy, Nishitha
Format: Artigo
Sprog:Inglês
Udgivet: e-Century Publishing Corporation 2012
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3384399/
https://ncbi.nlm.nih.gov/pubmed/22762027
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!